Correlation Between Basilea Pharmaceutica and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Basilea Pharmaceutica and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Salarius Pharmaceuticals.
Diversification Opportunities for Basilea Pharmaceutica and Salarius Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Basilea and Salarius is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Basilea Pharmaceutica and Salarius Pharmaceuticals
If you would invest 180.00 in Salarius Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of 35.00 from holding Salarius Pharmaceuticals or generate 19.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Basilea Pharmaceutica AG vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Basilea Pharmaceutica |
| Salarius Pharmaceuticals |
Basilea Pharmaceutica and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Basilea Pharmaceutica and Salarius Pharmaceuticals
The main advantage of trading using opposite Basilea Pharmaceutica and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.The idea behind Basilea Pharmaceutica AG and Salarius Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |